BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20028812)

  • 1. Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice.
    Johnston MJ; Wang A; Catarino ME; Ball L; Phan VC; MacDonald JA; McKay DM
    Infect Immun; 2010 Mar; 78(3):1364-75. PubMed ID: 20028812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages treated with antigen from the tapeworm Hymenolepis diminuta condition CD25
    Reyes JL; Lopes F; Leung G; Jayme TS; Matisz CE; Shute A; Burkhard R; Carneiro M; Workentine ML; Wang A; Petri B; Beck PL; Geuking MB; McKay DM
    FASEB J; 2019 Apr; 33(4):5676-5689. PubMed ID: 30668930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis.
    Hunter MM; Wang A; Hirota CL; McKay DM
    J Immunol; 2005 Jun; 174(11):7368-75. PubMed ID: 15905584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages.
    Reyes JL; Wang A; Fernando MR; Graepel R; Leung G; van Rooijen N; Sigvardsson M; McKay DM
    J Immunol; 2015 Jan; 194(1):364-78. PubMed ID: 25452561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triggering immunological memory against the tapeworm Hymenolepis diminuta to protect against colitis.
    Wang A; Arai T; Campbell A; Reyes JL; Lopes F; McKay DM
    Parasite Immunol; 2017 Nov; 39(11):. PubMed ID: 28892562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice.
    Hunter MM; Wang A; Parhar KS; Johnston MJ; Van Rooijen N; Beck PL; McKay DM
    Gastroenterology; 2010 Apr; 138(4):1395-405. PubMed ID: 20044996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Young mice expel the tapeworm Hymenolepis diminuta and are protected from colitis by triggering a memory response with worm antigen.
    Arai T; Lopes F; Shute A; Wang A; McKay DM
    Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G461-G470. PubMed ID: 29351392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the immuno-regulatory response to the tapeworm Hymenolepis diminuta in the non-permissive mouse host.
    Persaud R; Wang A; Reardon C; McKay DM
    Int J Parasitol; 2007 Mar; 37(3-4):393-403. PubMed ID: 17092505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-22 Restrains Tapeworm-Mediated Protection against Experimental Colitis via Regulation of IL-25 Expression.
    Reyes JL; Fernando MR; Lopes F; Leung G; Mancini NL; Matisz CE; Wang A; McKay DM
    PLoS Pathog; 2016 Apr; 12(4):e1005481. PubMed ID: 27055194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice.
    Melon A; Wang A; Phan V; McKay DM
    J Biomed Biotechnol; 2010; 2010():384523. PubMed ID: 20011066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helminth infection enhances disease in a murine TH2 model of colitis.
    Hunter MM; Wang A; McKay DM
    Gastroenterology; 2007 Apr; 132(4):1320-30. PubMed ID: 17408663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Trypsin-Sensitive Proteoglycan from the Tapeworm Hymenolepis diminuta Inhibits Murine Neutrophil Chemotaxis in vitro by Suppressing p38 MAP Kinase Activation.
    Graves N; Venu VP; Yipp BG; Petri B; Hirota S; Gilleard J; McKay DM; Lopes F
    J Innate Immun; 2019; 11(2):136-149. PubMed ID: 30205385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benign helminth Hymenolepis diminuta ameliorates chemically induced colitis in a rat model system.
    Jirků Pomajbíková K; Jirků M; Levá J; Sobotková K; Morien E; Parfrey LW
    Parasitology; 2018 Sep; 145(10):1324-1335. PubMed ID: 29909781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell deficiency in mice results in biomass overgrowth and delayed expulsion of the rat tapeworm
    González MI; Lopes F; McKay DM; Reyes JL
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with Cestode Parasite Antigens Results in Recruitment of CCR2+ Myeloid Cells, the Adoptive Transfer of Which Ameliorates Colitis.
    Reyes JL; Lopes F; Leung G; Mancini NL; Matisz CE; Wang A; Thomson EA; Graves N; Gilleard J; McKay DM
    Infect Immun; 2016 Dec; 84(12):3471-3483. PubMed ID: 27672083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils.
    Wang A; Fernando M; Leung G; Phan V; Smyth D; McKay DM
    Am J Pathol; 2010 Dec; 177(6):2850-9. PubMed ID: 21037078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of helminth antigen-pulsed dendritic cells protects against the development of experimental colitis in mice.
    Matisz CE; Leung G; Reyes JL; Wang A; Sharkey KA; McKay DM
    Eur J Immunol; 2015 Nov; 45(11):3126-39. PubMed ID: 26332354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tapeworm infection reduces epithelial ion transport abnormalities in murine dextran sulfate sodium-induced colitis.
    Reardon C; Sanchez A; Hogaboam CM; McKay DM
    Infect Immun; 2001 Jul; 69(7):4417-23. PubMed ID: 11401981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of colitis by adoptive transfer of helminth antigen-treated dendritic cells requires interleukin-4 receptor-α signaling.
    Matisz CE; Faz-López B; Thomson E; Al Rajabi A; Lopes F; Terrazas LI; Wang A; Sharkey KA; McKay DM
    Sci Rep; 2017 Jan; 7():40631. PubMed ID: 28094779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
    Ichikawa N; Yamashita K; Funakoshi T; Ichihara S; Fukai M; Ogura M; Kobayashi N; Zaitsu M; Yoshida T; Shibasaki S; Koshizuka Y; Tsunetoshi Y; Sato M; Einama T; Ozaki M; Umezawa K; Suzuki T; Todo S
    Inflamm Res; 2016 Mar; 65(3):245-60. PubMed ID: 26683259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.